Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome.
作者信息
Varney M E, Choi K, Bolanos L, Christie S, Fang J, Grimes H L, Maciejewski J P, Inoue J-I, Starczynowski D T
机构信息
Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
出版信息
Leukemia. 2017 Feb;31(2):491-495. doi: 10.1038/leu.2016.276. Epub 2016 Oct 3.
Abstract
摘要
相似文献
1
Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome.TIFAB与miR-146a之间的上位性：5号染色体长臂缺失骨髓增生异常综合征中的相邻基因
Leukemia. 2017 Feb;31(2):491-495. doi: 10.1038/leu.2016.276. Epub 2016 Oct 3.
2
Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network.伴有5号染色体长臂缺失的髓系恶性肿瘤对染色体内部的核因子κB基因网络产生依赖。
Cell Rep. 2014 Sep 11;8(5):1328-38. doi: 10.1016/j.celrep.2014.07.062. Epub 2014 Sep 4.
3
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.鉴定 miR-145 和 miR-146a 作为 5q-综合征表型的介质。
Nat Med. 2010 Jan;16(1):49-58. doi: 10.1038/nm.2054. Epub 2009 Nov 8.
4
Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling.Tifab（一种5号染色体长臂缺失相关的骨髓增生异常综合征基因）的缺失通过解除Toll样受体-TRAF6信号通路的抑制来改变造血作用。
J Exp Med. 2015 Oct 19;212(11):1967-85. doi: 10.1084/jem.20141898. Epub 2015 Oct 12.
5
Deletion 5q MDS: molecular and therapeutic implications.5q 缺失 MDS 的分子与治疗学意义。
Best Pract Res Clin Haematol. 2013 Dec;26(4):365-75. doi: 10.1016/j.beha.2013.10.013. Epub 2013 Oct 16.
6
Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide.来那度胺治疗的伴有5号染色体长臂缺失（del(5q)）的骨髓增生异常综合征的全基因组miRNA分析
Eur J Haematol. 2015 Jul;95(1):35-43. doi: 10.1111/ejh.12458. Epub 2014 Nov 11.
7
Differential expression of microRNAs in CD34+ cells of 5q- syndrome.5q- 综合征中 CD34+ 细胞中 microRNAs 的差异表达。
J Hematol Oncol. 2011 Jan 6;4:1. doi: 10.1186/1756-8722-4-1.
8
5q- syndrome.5q- 综合征。
Curr Pharm Des. 2012;18(22):3180-3. doi: 10.2174/1381612811209023180.
9
10
Two different del(5q) clones in a patient with myelodysplastic syndrome.一名骨髓增生异常综合征患者体内的两种不同的5号染色体长臂缺失克隆。
Leuk Lymphoma. 2011 Sep;52(9):1811-4. doi: 10.3109/10428194.2011.575968. Epub 2011 Jun 10.
引用本文的文献
1
Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML.失调的先天免疫信号传导与RUNX1突变协同作用，将类似骨髓增生异常综合征的疾病转化为急性髓系白血病。
iScience. 2024 Apr 24;27(6):109809. doi: 10.1016/j.isci.2024.109809. eCollection 2024 Jun 21.
2
TIFAB regulates the TIFA-TRAF6 signaling pathway involved in innate immunity by forming a heterodimer complex with TIFA.TIFAB 通过与 TIFA 形成异二聚体复合物来调节参与固有免疫的 TIFA-TRAF6 信号通路。
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2318794121. doi: 10.1073/pnas.2318794121. Epub 2024 Mar 5.
3
ABIN1 (Q478) is Required to Prevent Hematopoietic Deficiencies through Regulating Type I IFNs Expression.ABIN1（Q478）通过调节 I 型干扰素的表达来防止造血缺陷。
Adv Sci (Weinh). 2024 Jan;11(3):e2303555. doi: 10.1002/advs.202303555. Epub 2023 Nov 27.
4
Activation of distinct inflammatory pathways in subgroups of LR-MDS.LR-MDS 亚组中不同炎症通路的激活。
Leukemia. 2023 Aug;37(8):1709-1718. doi: 10.1038/s41375-023-01949-2. Epub 2023 Jul 7.
5
Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation.在炎症期间，p53 的失活为 del(5q) 骨髓增生异常综合征造血干细胞提供了竞争优势。
Haematologica. 2023 Oct 1;108(10):2715-2729. doi: 10.3324/haematol.2022.282349.
6
Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS.髓源性抑制细胞：骨髓增生异常综合征发病机制与治疗的新见解
J Clin Med. 2022 Aug 21;11(16):4908. doi: 10.3390/jcm11164908.
7
NPM1 ablation induces HSC aging and inflammation to develop myelodysplastic syndrome exacerbated by p53 loss.NPM1 缺失导致造血干细胞衰老和炎症，进而发展为骨髓增生异常综合征，并被 p53 缺失所加剧。
EMBO Rep. 2022 May 4;23(5):e54262. doi: 10.15252/embr.202154262. Epub 2022 Mar 1.
8
Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins.泛素和类泛素蛋白修饰的急性髓系白血病相关蛋白。
Int J Mol Sci. 2022 Jan 3;23(1):514. doi: 10.3390/ijms23010514.
9
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies.IRAK1 和 IRAK4 作为血液系统恶性肿瘤中新兴的治疗靶点。
Curr Opin Hematol. 2022 Jan 1;29(1):8-19. doi: 10.1097/MOH.0000000000000693.
10
Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS.造血衰老、克隆性造血和骨髓增生异常综合征中的固有免疫途径与炎症
J Exp Med. 2021 Jul 5;218(7). doi: 10.1084/jem.20201544. Epub 2021 Jun 15.
本文引用的文献
1
Retroviral insertional mutagenesis identifies the del(5q) genes, CXXC5, TIFAB and ETF1, as well as the Wnt pathway, as potential targets in del(5q) myeloid neoplasms.逆转录病毒插入诱变确定了5号染色体长臂缺失（del(5q)）相关基因CXXC5、TIFAB和ETF1，以及Wnt信号通路，它们是del(5q)骨髓肿瘤的潜在靶点。
Haematologica. 2016 Jun;101(6):e232-6. doi: 10.3324/haematol.2015.139527. Epub 2016 Mar 4.
2
Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling.Tifab（一种5号染色体长臂缺失相关的骨髓增生异常综合征基因）的缺失通过解除Toll样受体-TRAF6信号通路的抑制来改变造血作用。
J Exp Med. 2015 Oct 19;212(11):1967-85. doi: 10.1084/jem.20141898. Epub 2015 Oct 12.
3
Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network.伴有5号染色体长臂缺失的髓系恶性肿瘤对染色体内部的核因子κB基因网络产生依赖。
Cell Rep. 2014 Sep 11;8(5):1328-38. doi: 10.1016/j.celrep.2014.07.062. Epub 2014 Sep 4.
4
MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice.微小RNA-146a在小鼠中作为造血干细胞质量和寿命的守护者。
Elife. 2013 May 21;2:e00537. doi: 10.7554/eLife.00537.
5
NetWalker: a contextual network analysis tool for functional genomics.NetWalker：一种用于功能基因组学的语境网络分析工具。
BMC Genomics. 2012 Jun 25;13:282. doi: 10.1186/1471-2164-13-282.
6
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited.重新探讨 5q 髓系恶性肿瘤的解剖学、临床和基因组相关性。
J Clin Oncol. 2012 Apr 20;30(12):1343-9. doi: 10.1200/JCO.2011.36.1824. Epub 2012 Feb 27.
7
NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies.miR-146a 缺陷型小鼠中 NF-κB 的失调导致髓系恶性肿瘤的发生。
Proc Natl Acad Sci U S A. 2011 May 31;108(22):9184-9. doi: 10.1073/pnas.1105398108. Epub 2011 May 16.
8
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice.miR-146a 是小鼠自身免疫、骨髓增生和癌症的重要制动因素。
J Exp Med. 2011 Jun 6;208(6):1189-201. doi: 10.1084/jem.20101823. Epub 2011 May 9.
9
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.骨髓增生异常综合征造血干细胞中失调的基因表达途径。
Leukemia. 2010 Apr;24(4):756-64. doi: 10.1038/leu.2010.31. Epub 2010 Mar 11.
10
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.鉴定 miR-145 和 miR-146a 作为 5q-综合征表型的介质。
Nat Med. 2010 Jan;16(1):49-58. doi: 10.1038/nm.2054. Epub 2009 Nov 8.
Zotero 插件